Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
Development Of DMT Transdermal Patch With Eye Disease Treatment In Mind
February 22, 2023
From Benzinga
2C-B Vs. Psilocybin: New Study Shares Insightful Trial Results On The Mescaline-Derived Psychedelic's Effects
February 21, 2023
From Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
February 21, 2023
From Benzinga
From Benzinga
Algernon Touts Positive Study Findings, Confirms Next Trial Phase With Escalated Dose
February 16, 2023
Tickers
AGNPF
From Benzinga
Novel Combination Of Cannabis-Like Compound With Classical Psychedelics Searches IP Coverage In US
February 15, 2023
From Benzinga
Psychedelics For Alcohol Use Disorder: Awakn Opens European Clinic, FSD Launches R&D Program
February 14, 2023
From Benzinga
Psychedelics States Reform: Utah, Iowa and Missouri's New Bills, Hawaii And Arizona's Green Lights, New Hampshire's Setback
February 13, 2023
From Benzinga
Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More
February 13, 2023
From Benzinga
Testing Psychedelics Efficacy On 'Psychiatry's Blind Spot': Latest King's College Trial
February 13, 2023
From Benzinga
From Benzinga
How Do Psilocybin And MDMA Work Together? This Proposed Experiential Study Is Set To Find Out
February 09, 2023
Tickers
OPTHF
From Benzinga
Psychedelics Legislation: Here's The Latest On Hawaii, Virginia, Missouri And More
February 08, 2023
From Benzinga
EXCLUSIVE: Social Equity, Adult-Use, Commercialization & Regs For Psychedelics, Lessons From Cannabis
February 08, 2023
From Benzinga
Australia's Psychedelics Therapy Provides Hope For Treatment-Resistant Mental Health Conditions
February 07, 2023
Tickers
NUMIF
From Benzinga
US Universities Ride The Psychedelics Wave With New Programs In Their Medical Schools
February 06, 2023
From Benzinga
EXCLUSIVE: Fox Rothschild Cannabis Attorney Analyzes Psychedelics Regs And Changing Public Perceptions
February 06, 2023
Tickers
CMPS
From Benzinga
Silo Pharma, Mindset Pharma, Terran Biosciences Receive Psychedelic Treatments Patents, IP Portfolios Expanded
February 03, 2023
From Benzinga
State-Level Psychedelics Bills: Hawaii And West Virginia, NY And NH Bolster And VA Advances
February 03, 2023
From Benzinga
'Sea Change': Irwin Naturals, Numinus And Field Trip Discuss Psychedelics At Cantor Webinar
February 03, 2023
From Benzinga
Canadian Psychedelics Company Launches Take-Home Psilocybin Trial For Some 300 Participants
February 01, 2023
From Benzinga
Race Is On For Psychedelic DMT-Related Compounds, Small Pharma, Inc To Issue Two New Patents
February 01, 2023
Tickers
DMTTF
From Benzinga
This Psychedelic-Assisted Therapy Study Offers Therapists Experience With Magic Mushroom Tea
February 01, 2023
Tickers
NUMIF
From Benzinga
EXCLUSIVE: Next-Generation Psychedelics, MEAI - The Road Ahead
February 01, 2023
Tickers
CMND
From Benzinga
Colorado's Psychedelics Bill Advances: Gov. Polis Appoints Natural Medicine Advisory Board
January 31, 2023
From Benzinga
Learn How To Safely Facilitate Psychedelic Therapy With These New Training Programs
January 27, 2023
From Benzinga
BetterLife Engages Canadian Healthcare Investment Firm, Aims For Clinical Trial Programs
January 26, 2023
Tickers
BETRF
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
